OCUL OCULAR THERAPEUTIX, INC
Price Chart
Executive Summary
Four OCUL insiders, including the Chief Scientific Officer and Chief Development Officer, conducted open-market sales of 28,999 shares for $238K, all at $8.20 on May 26, 2026. The cluster is small in magnitude (0.01% of the $1.9B market cap), concentrated on a single date, and likely driven by a shared trading-window opening or tax-planning event — not material negative information. The $0 gift of 394,696 shares by Dugel Pravin has no economic impact. Net direction is selling but routine for a mid-cap pharma company.
Key Financial Metrics
Actionable Insight
This is a low-signal insider cluster. The identical price ($8.20) and single-day concentration across multiple executives suggest a 10b5-1 plan or window-opening event rather than opportunistic selling. Lab-lead (CSO, CDO) participation also points to vesting-driven sales, not fundamental concern. Ignore for trading. Monitor the 30-day pipeline for any material clinical news that might have motivated the gift.
Key Facts
- Four C-suite/executive insiders sold 28,999 shares in open-market transactions on May 26, 2026, all at $8.20/share.
- Total cluster sales value: $237,792 — just 0.013% of OCUL's $1.9B market cap (well below the 0.1% triviality threshold).
- Dugel Pravin additionally gifted 394,696 shares on May 28 at $0 (non-economic event).
- No purchases occurred in the cluster window; the net direction is selling.
- The sales are small in dollar terms and cluster on a single date, consistent with a routine blackout-window opening or end-of-month 10b5-1 plan execution.
Financial Impact
Total insider sales of $238K represent 0.013% of market cap — economically trivial.
Risk Factors
- Historical performance on OCUL filing reports shows a 38% win rate and -6.91% average T+20 return — prior high-signal reads on this name have not been rewarded.
- A 394K-share gift by Dugel Pravin could precede share transfers to a trust or family member — no immediate price impact, but may reduce beneficial-owner alignment.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-OCUL-1779999078058 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
today
|
8-K
| $8.94 awaiting T+1 | awaiting T+1 | — | $8.94 (−0.00%) |
|
Jun 4, 2026
8d ago
|
Press Release
| $8.80 $8.25 | ▼ −6.25% | ▼ −3.65% | $8.94 (+1.59%) |
|
May 28, 2026
15d ago
|
Insider Cluster
| $9.01 $8.93 | ▼ −0.89% | ▼ −1.15% | $8.94 (−0.78%) |
|
May 5, 2026
5w ago
|
8-K
| $9.71 $9.71 | · 0.00% | ▼ −1.38% | $8.94 (−7.93%) |
|
May 5, 2026
5w ago
|
Press Release
| $9.71 $9.71 | · 0.00% | ▼ −1.38% | $8.94 (−7.93%) |
|
Apr 30, 2026
6w ago
|
DEFA14A
| $9.43 $9.77 | ▲ +3.61% | ▲ +3.95% | $8.94 (−5.20%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $8.86 $8.76 | ▼ −1.13% | ▼ −2.34% | $8.94 (+0.90%) |
|
Apr 1, 2026
10w ago
|
Press Release
| $8.33 $8.49 | ▲ +1.92% | ▲ +1.84% | $8.94 (+7.32%) |
|
Feb 20, 2026
16w ago
|
Insider Cluster
| $7.78 $8.41 | ▲ +8.10% | ▲ +9.11% | $8.94 (+14.91%) |
|
Feb 20, 2026
16w ago
|
Insider Cluster
| $7.78 $8.41 | ▲ +8.10% | ▲ +9.11% | $8.94 (+14.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access